Bridging academic borders: King's International fellowships in movement disorders and neuro-rehabilitation
King's Dubai's Parkinson's Centre of Excellence pioneers global clinical and research training
King's College Hospital London-Dubai is leading the way in international clinical and research training with its pioneering fellowships in Movement Disorders and Neuro-Rehabilitation. Notably, the programme has launched the first-ever Indonesian Visiting Fellowship in Dubai, fostering cross-border academic exchange and medical expertise.
Dr Merrie, a consultant in neuro-rehabilitation at EMC Hospitals in Jakarta, recently completed her fellowship in Movement Disorders and Parkinson's under the mentorship of Dr Vinod Metta, program director at King's College Hospital Dubai. Reflecting on her experience, she highlighted the invaluable opportunity to manage complex Parkinson's cases and advanced movement disorders. She also had the rare chance to witness and study conditions such as corticobasal degeneration, ocular apraxia, and alien limb syndrome - diseases she had previously only encountered in textbooks. Additionally, her hands-on training included administering EMG-guided botulinum injections for dystonia and spasticity, as well as managing elevated intracranial pressure, under the guidance of Dr Metta and professor Ray Chaudhuri.
Similarly, Mohammed, a neuro-physiotherapist, undertook a specialised Parkinson's neuro-rehabilitation training programme under Dr Metta's supervision. He was particularly impressed by the comprehensive, multidisciplinary approach at the Parkinson's Centre of Excellence, which seamlessly integrates neurophysiotherapy, speech and language therapy, and occupational therapy to manage patients across different races, ages, and stages of Parkinson's. He emphasised how the fellowship provided him with invaluable expertise in handling complex movement disorder cases, which will significantly benefit his work in Jakarta.
Both Dr Merrie and Mohammed extended their heartfelt gratitude to EMC Hospitals' management - Pak Jusup, Dr Juni, Dr Metta, and Dr Sedjaya - for nominating them for this prestigious overseas training. They also expressed appreciation to King's Dubai's management team, including Kimberley Pierce and Norafiz Gee, for their support. A special mention was given to the programme directors, Dr Vinod Metta and professor Ray Chaudhuri, along with esteemed mentors Dr Guy Chung-Faye, Dr George Kapsas, Dr Nicandro, and Dr John, for their invaluable guidance.
Dr Metta emphasised that King's Dubai's Parkinson's Centre of Excellence is committed to delivering world-class visiting fellowships. These programmes offer neurology residents, junior neurologists, neuro-rehabilitation consultants, and neuro-physiotherapists in-depth, hands-on training in managing a wide spectrum of movement disorders and Parkinson's disease. Fellows also gain expertise in neurophysiology, neuroradiology, and neuro-spine. He expressed his satisfaction with the overwhelmingly positive feedback from the first cohort of visiting fellows and looks forward to expanding the initiative further.
This groundbreaking fellowship initiative reinforces King's Dubai's commitment to advancing global medical training and fostering cross-border knowledge exchange in movement disorders and neuro-rehabilitation.
For more information about King's movement disorders, Parkinson's and neuro-rehabilitation training, as well as short-term visiting fellowships and PhD/doctoral programmes, please contact: ehabadly.awad@kch.a
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
42 minutes ago
- Zawya
Marhaba partners with PRIME Health to provide world-class travel services for Dubai's medical tourists
Dubai, UAE – marhaba, part of dnata and a leading global airport hospitality brand, has partnered with PRIME Health to provide premium travel services for passengers arriving in Dubai for medical treatment. Driven by a commitment to patient well-being, the partnership ensures a smooth and stress-free travel experience that complements the quality of care provided by PRIME Health. marhaba will provide its full airport hospitality offering to support medical travellers, including its signature Meet & Greet, Chauffeur and Lounge services. In addition, its recently announced Check-in Anywhere and Land & Leave solutions will further enhance the journey, enabling a smooth, hands-free experience from arrival to departure. Jaffar Dawood, dnata's Divisional Senior Vice President - UAE Airport Operations, said: 'We are pleased to partner with PRIME Health to further enhance the medical tourism experience in Dubai. With marhaba's personalised service and Arabian hospitality, twinned with Dubai's world-class infrastructure, we ensure medical travellers feel looked after from the moment they land. This partnership reflects our shared focus on care, comfort and service excellence.' Dr. Jamil Ahmed, Founder and Managing Director, PRIME Health, said: 'At PRIME Health, we believe exceptional care starts well before a patient enters the hospital. Our partnership with marhaba ensures international patients receive a warm, stress-free welcome the moment they land. By combining world-class hospitality with trusted medical expertise, we are redefining the healthcare journey making it as seamless and supportive as possible from arrival to recovery.' Dubai welcomed over 691,000 people for medical treatments in 2023, with spending on healthcare services exceeding AED 1.03 billion (US$ 280 million). The emirate is rapidly positioning itself as a leading global destination for medical tourism, combining advanced healthcare with world-class luxury and personalised care. According to PRIME Health, international patient flows to Dubai have grown across diverse medical specialisms, with dentistry, dermatology, cardiology, and fertility treatments leading demand. Medical tourists increasingly seek Dubai's orthopaedic treatments, particularly joint replacement surgeries, and the city's range of the latest cosmetic treatments also remain popular with visitors. As part of its growing network, PRIME Health also operates medical centres within terminals one and three at Dubai International airport (DXB), providing convenient access to high-quality care for travellers. marhaba, which means 'welcome' in Arabic, was launched in the UAE to help passengers arriving in or departing from Dubai International airport. The popularity of meet & greet services has grown exponentially in line with Dubai's growth as a major international travel hub, and marhaba has continually expanded its product offering with a growing list of services and extra options designed to make the passenger airport experience as comfortable as possible. The marhaba brand is part of dnata, one of the world's largest air services providers. A trusted partner of over 300 airline customers, dnata offers ground handling, cargo, travel catering & retail services in over 30 countries across six continents. Contact marhaba Public Relations
Khaleej Times
13 hours ago
- Khaleej Times
'Legacy will live on': Hundreds gather in Dubai to mourn renowned Indian doctor
Hundreds of people gathered at Al Quoz cemetery late on Sunday to bid farewell to Dr Nazar Moopan, a well-loved member of the medical community and nephew of Dr Azad Moopen, Founder Chairman of Aster DM Healthcare. Well-wishers and friends flew in from India and other Gulf countries to pay their respects to the doctor who passed away peacefully in Dubai on Sunday, surrounded by his family. 'It is with deep sorrow and a profound sense of loss that we mourn the passing of Dr Nazar Moopan,' said Dr Azad Moopen. 'Dr Nazar was not only a pillar of our medical community but also a compassionate doctor, a committed leader, and a beloved colleague to many within the Aster family. For over two decades, Dr Nazar has worked at Aster DM Healthcare and at the time of his death, he was the Medical Director and ENT Consultant at the group's facility in Qatar. He is survived by his wife Wahida and his children Neda, Nimmi and Zain. According to Dr Azad, Dr Nazar 'dedicated his life to the service of others' for decades, exemplifying the values of integrity, excellence, and empathy. 'His contributions to healthcare in Qatar have left an indelible mark, and his legacy will live on through the countless lives he touched with his skill and kindness,' he said.
Khaleej Times
20 hours ago
- Khaleej Times
No more insulin injections for diabetes patients? UAE doctors explain cell-based treatment
Many diabetic patients abroad have said goodbye to insulin injections or now use them less frequently and in lower doses, according to doctors who noted patients recovered after undergoing a simple surgical procedure to transplant pancreatic cells. "50 per cent of patients with Type 1 diabetes — who typically rely on insulin injections — have been cured through 'islet cell transplantation'," Dr Tahra Abdalla Al Ali, a pediatrician based in the UAE, told Khaleej Times. "This has cured people of their pancreas's inability to produce insulin. Patients will no longer depend on insulin as they look forward to a future without constant insulin management.' Dr Al Ali noted, 'In 25 cases, pancreatic cells were transplanted; and the success rate for this group was 85 per cent. Of the patients, 50 per cent completely stopped using medication. The remaining group members use injections at lower doses and less frequently.' Stay up to date with the latest news. Follow KT on WhatsApp Channels. This treatment, which aims to benefit all patient groups, initially targeted individuals over the age of 20 who suffered from complications of diabetes and had difficulty maintaining healthy levels for an extended period. Procedure explained Dr Al Ali said islet cell transplantation involves transplanting pancreatic cells extracted from donors and studying them in specialised laboratories. Once the safety of these samples is confirmed, they are injected into the patient using a catheter-like method through the skin into a vein and then transplanted onto the liver. 'The transplanted cells help restore and regulate blood sugar levels in patients with type 1 diabetes, preventing severe, life-threatening hypoglycemia episodes and allowing patients to eliminate their daily insulin injections,' she added. Simple and safe The procedure is considered an alternative to the complete pancreas transplant to avoid surgical complications, including organ rejection and bleeding. It is regarded as a safe and simple treatment method. The Emirates Health Services (EHS), in collaboration with the University of Chicago, is working to treat patients from the UAE either abroad or by bringing experts to the country to provide care. Only for Type 1 diabetes The procedure is used exclusively for patients with Type 1 diabetes, where the main issue is the destruction of insulin-producing beta cells, Dr Patanjali Panduranga, endocrinologist at Aster Hospital, explained. It is not considered a treatment for Type 2 diabetes, where insulin resistance is the primary problem. However, some early studies are exploring its use in selected cases of insulin-dependent type 2 diabetes, although this remains under investigation. He noted the US Food and Drug Administration (FDA) approved islet cell transplantation in 2023 for adults with Type 1 diabetes who experienced severe hypoglycemia or poor glucose control despite intensive insulin therapy. Limitations remain 'Although the procedure has shown promising results, including insulin independence in up to 50 per cent of recipients, its broader clinical use remains limited due to the need for lifelong immunosuppression and the scarcity of suitable donor cells,' said Dr Panduranga. Dr Arvind Gaddameedi, another endocrinologist at Aster Clinic, explained that the success of islet cell transplantation depends on two key factors, safety and sustainability. Unlike full organ transplants, this procedure involves a 30-minute infusion under local anesthesia, making it accessible even to high-risk patients. However, challenges remain. One of the challenges is the availability of donor cells. While organ donation rates vary globally, innovations in islet cell processing, cryopreservation, and even stem cell-derived islets, currently under trial, may soon expand accessibility. 'These developments represent a new dawn in diabetes care. While not yet a first-line treatment, islet cell transplantation is a vital option for patients struggling with the demands of insulin therapy. As research progresses, improvements in immunosuppression, donor matching, and cell supply are expected to make this treatment more widely available.'
